| There’s one tiny biotech on the verge of a breakthrough dementia treatment…
Biogen, the only biotech to get a new Alzheimer’s drug approved in the past 20 years, made a $1 billion investment in this company.
Get the name of the small biotech here >>>
“The Buck Stops Here,” |
